Bluestein R H & CO LLC Bristol Myers Squibb CO Transaction History

Bluestein R H & CO LLC

  • $1.61 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$59.92 - $68.98 $276,830 - $318,687
-4,620 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $162,437 - $177,098
-2,710 Reduced 36.97%
4,620 $283,000
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $404,835 - $467,214
7,330
7,330 $467,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email